Guarantors - Consolidating Statements of Cash Flows (Details) - USD ($) | 3 Months Ended | 6 Months Ended |
Jun. 30, 2016 | Mar. 31, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | $ 9,100,000 | | $ (6,500,000) | $ 14,700,000 | $ (13,700,000) |
Equity income (loss) related to investment in subsidiaries | | | | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 44,700,000 | | 31,400,000 | 84,000,000 | 62,500,000 |
Non-cash interest expense | | | | 1,500,000 | 1,400,000 |
Stock-based compensation expense | | | | 6,200,000 | 6,200,000 |
Provision for bad debt | | | | 700,000 | 200,000 |
Asset impairments and loss on disposal | 0 | | 0 | 0 | 8,600,000 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | (8,900,000) | (7,800,000) |
Accounts payable and accrued expenses | | | | 1,700,000 | 5,400,000 |
Deferred revenues | | | | (7,000,000) | 800,000 |
Due to affiliates | | | | 0 | (1,900,000) |
Net cash provided by operating activities | | | | 92,900,000 | 61,700,000 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | (131,100,000) | (17,300,000) |
Capital expenditures – other development | | | | (247,100,000) | (74,200,000) |
Investment in subsidiaries | | | | 0 | 0 |
Changes in restricted cash | | | | 1,200,000 | 0 |
Return of investment | | | | 0 | 0 |
Intercompany borrowings | | | | 0 | |
Intercompany contributions/distributions | | | | | 0 |
Net cash used in investing activities | | | | (377,000,000) | (91,500,000) |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | $ 256,000,000 | | 256,500,000 | 799,300,000 |
Stock issuance costs | | | | (500,000) | (600,000) |
Acquisition of partnership units | | | | 0 | (426,000,000) |
Dividends paid | | | | (52,900,000) | (33,800,000) |
Intercompany borrowings | | | | 0 | 0 |
Borrowings from credit facility | | | | 415,000,000 | 70,000,000 |
Payments on credit facility | | | | (315,000,000) | 0 |
Payments on capital leases and leasing financing arrangements | | | | (4,400,000) | (2,100,000) |
Tax payment upon exercise of equity awards | | | | 13,600,000 | 0 |
Contributions/distributions from parent | | | | 0 | 0 |
Debt issuance costs | | | | (2,100,000) | 0 |
Net cash provided by financing activities | | | | 283,000,000 | 406,800,000 |
Net increase (decrease) in cash and cash equivalents | | | | (1,100,000) | 377,000,000 |
Cash and cash equivalents at beginning of period | | 14,300,000 | | 14,300,000 | 36,500,000 |
Cash and cash equivalents at end of period | 13,200,000 | | 413,500,000 | 13,200,000 | 413,500,000 |
General Partner | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | 0 | | (100,000) | 100,000 | (200,000) |
Equity income (loss) related to investment in subsidiaries | | | | (100,000) | 200,000 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 0 | | 0 | 0 | 0 |
Non-cash interest expense | | | | 0 | 0 |
Stock-based compensation expense | | | | 0 | 0 |
Provision for bad debt | | | | 0 | 0 |
Asset impairments and loss on disposal | | | | 0 | 0 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | 0 | 0 |
Accounts payable and accrued expenses | | | | 0 | 0 |
Deferred revenues | | | | 0 | 0 |
Due to affiliates | | | | | 0 |
Net cash provided by operating activities | | | | 0 | 0 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | 0 | 0 |
Capital expenditures – other development | | | | 0 | 0 |
Investment in subsidiaries | | | | (2,600,000) | 0 |
Changes in restricted cash | | | | 0 | |
Return of investment | | | | 0 | (2,000,000) |
Intercompany borrowings | | | | 0 | |
Intercompany contributions/distributions | | | | | 0 |
Net cash used in investing activities | | | | (2,600,000) | (2,000,000) |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 0 | 0 |
Stock issuance costs | | | | 0 | 0 |
Acquisition of partnership units | | | | | 0 |
Dividends paid | | | | 0 | 0 |
Intercompany borrowings | | | | 0 | 0 |
Borrowings from credit facility | | | | 0 | 0 |
Payments on credit facility | | | | 0 | |
Payments on capital leases and leasing financing arrangements | | | | 0 | 0 |
Tax payment upon exercise of equity awards | | | | 0 | |
Contributions/distributions from parent | | | | 2,600,000 | 2,000,000 |
Debt issuance costs | | | | 0 | |
Net cash provided by financing activities | | | | 2,600,000 | 2,000,000 |
Net increase (decrease) in cash and cash equivalents | | | | 0 | 0 |
Cash and cash equivalents at beginning of period | | 0 | | 0 | 0 |
Cash and cash equivalents at end of period | 0 | | 0 | 0 | 0 |
Eliminations/Consolidations | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | (25,700,000) | | 6,400,000 | (46,800,000) | 12,600,000 |
Equity income (loss) related to investment in subsidiaries | | | | 48,500,000 | (11,200,000) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 0 | | 0 | 0 | 0 |
Non-cash interest expense | | | | 0 | 0 |
Stock-based compensation expense | | | | 0 | 0 |
Provision for bad debt | | | | 0 | 0 |
Asset impairments and loss on disposal | | | | 0 | 0 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | 0 | 0 |
Accounts payable and accrued expenses | | | | 0 | 0 |
Deferred revenues | | | | 0 | 0 |
Due to affiliates | | | | | 0 |
Net cash provided by operating activities | | | | 1,700,000 | 1,400,000 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | 0 | 0 |
Capital expenditures – other development | | | | 0 | 0 |
Investment in subsidiaries | | | | 515,200,000 | 0 |
Changes in restricted cash | | | | 0 | |
Return of investment | | | | (50,800,000) | (58,000,000) |
Intercompany borrowings | | | | (4,900,000) | |
Intercompany contributions/distributions | | | | | 70,000,000 |
Net cash used in investing activities | | | | 459,500,000 | 12,000,000 |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 0 | 0 |
Stock issuance costs | | | | 0 | 0 |
Acquisition of partnership units | | | | | 0 |
Dividends paid | | | | 50,800,000 | 59,200,000 |
Intercompany borrowings | | | | 3,200,000 | (70,000,000) |
Borrowings from credit facility | | | | 0 | 0 |
Payments on credit facility | | | | 0 | |
Payments on capital leases and leasing financing arrangements | | | | 0 | 0 |
Tax payment upon exercise of equity awards | | | | 0 | |
Contributions/distributions from parent | | | | (515,200,000) | (2,600,000) |
Debt issuance costs | | | | 0 | |
Net cash provided by financing activities | | | | (461,200,000) | (13,400,000) |
Net increase (decrease) in cash and cash equivalents | | | | 0 | 0 |
Cash and cash equivalents at beginning of period | | 0 | | 0 | 0 |
Cash and cash equivalents at end of period | 0 | | 0 | 0 | 0 |
Total Stockholders' Equity/ Parent’s Net Investment | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | 7,800,000 | | (6,200,000) | 13,000,000 | (11,200,000) |
Equity income (loss) related to investment in subsidiaries | | | | (13,000,000) | 11,200,000 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 0 | | 0 | 0 | 0 |
Non-cash interest expense | | | | 0 | 0 |
Stock-based compensation expense | | | | 0 | 0 |
Provision for bad debt | | | | 0 | 0 |
Asset impairments and loss on disposal | | | | 0 | 0 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | 0 | 0 |
Accounts payable and accrued expenses | | | | 0 | 0 |
Deferred revenues | | | | 0 | 0 |
Due to affiliates | | | | | 0 |
Net cash provided by operating activities | | | | 0 | 0 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | 0 | 0 |
Capital expenditures – other development | | | | 0 | 0 |
Investment in subsidiaries | | | | (256,300,000) | (373,300,000) |
Changes in restricted cash | | | | 0 | |
Return of investment | | | | 50,800,000 | 26,000,000 |
Intercompany borrowings | | | | 14,000,000 | |
Intercompany contributions/distributions | | | | | 0 |
Net cash used in investing activities | | | | (191,500,000) | (347,300,000) |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 256,500,000 | 799,300,000 |
Stock issuance costs | | | | (500,000) | (600,000) |
Acquisition of partnership units | | | | | (426,000,000) |
Dividends paid | | | | (50,900,000) | (25,400,000) |
Intercompany borrowings | | | | 0 | 0 |
Borrowings from credit facility | | | | 0 | 0 |
Payments on credit facility | | | | 0 | |
Payments on capital leases and leasing financing arrangements | | | | 0 | 0 |
Tax payment upon exercise of equity awards | | | | 13,600,000 | |
Contributions/distributions from parent | | | | 0 | 0 |
Debt issuance costs | | | | 0 | |
Net cash provided by financing activities | | | | 191,500,000 | 347,300,000 |
Net increase (decrease) in cash and cash equivalents | | | | 0 | 0 |
Cash and cash equivalents at beginning of period | | 0 | | 0 | 0 |
Cash and cash equivalents at end of period | 0 | | 0 | 0 | 0 |
LP Co-issuer | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | 7,800,000 | | (7,200,000) | 13,000,000 | (15,100,000) |
Equity income (loss) related to investment in subsidiaries | | | | (36,800,000) | (1,800,000) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 0 | | 0 | 0 | 0 |
Non-cash interest expense | | | | 1,500,000 | 1,400,000 |
Stock-based compensation expense | | | | 0 | 0 |
Provision for bad debt | | | | 0 | 0 |
Asset impairments and loss on disposal | | | | 0 | 0 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | 0 | (2,900,000) |
Accounts payable and accrued expenses | | | | 0 | 13,000,000 |
Deferred revenues | | | | 0 | 0 |
Due to affiliates | | | | | 0 |
Net cash provided by operating activities | | | | (22,300,000) | (5,400,000) |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | 0 | 0 |
Capital expenditures – other development | | | | 0 | 0 |
Investment in subsidiaries | | | | (256,300,000) | 0 |
Changes in restricted cash | | | | 0 | |
Return of investment | | | | 0 | 39,200,000 |
Intercompany borrowings | | | | (8,800,000) | |
Intercompany contributions/distributions | | | | | (70,000,000) |
Net cash used in investing activities | | | | (265,100,000) | (30,800,000) |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 0 | 0 |
Stock issuance costs | | | | 0 | 0 |
Acquisition of partnership units | | | | | 0 |
Dividends paid | | | | (52,800,000) | (33,800,000) |
Intercompany borrowings | | | | (14,000,000) | 0 |
Borrowings from credit facility | | | | 415,000,000 | 70,000,000 |
Payments on credit facility | | | | (315,000,000) | |
Payments on capital leases and leasing financing arrangements | | | | 0 | 0 |
Tax payment upon exercise of equity awards | | | | 0 | |
Contributions/distributions from parent | | | | 256,300,000 | 0 |
Debt issuance costs | | | | (2,100,000) | |
Net cash provided by financing activities | | | | 287,400,000 | 36,200,000 |
Net increase (decrease) in cash and cash equivalents | | | | 0 | 0 |
Cash and cash equivalents at beginning of period | | 0 | | 0 | 0 |
Cash and cash equivalents at end of period | 0 | | 0 | 0 | 0 |
Finance Co-issuer | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | 0 | | 0 | 0 | 0 |
Equity income (loss) related to investment in subsidiaries | | | | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 0 | | 0 | 0 | 0 |
Non-cash interest expense | | | | 0 | 0 |
Stock-based compensation expense | | | | 0 | 0 |
Provision for bad debt | | | | 0 | 0 |
Asset impairments and loss on disposal | | | | 0 | 0 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | 0 | 0 |
Accounts payable and accrued expenses | | | | 0 | 0 |
Deferred revenues | | | | 0 | 0 |
Due to affiliates | | | | | 0 |
Net cash provided by operating activities | | | | 0 | 0 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | 0 | 0 |
Capital expenditures – other development | | | | 0 | 0 |
Investment in subsidiaries | | | | 0 | 0 |
Changes in restricted cash | | | | 0 | |
Return of investment | | | | 0 | 0 |
Intercompany borrowings | | | | 0 | |
Intercompany contributions/distributions | | | | | 0 |
Net cash used in investing activities | | | | 0 | 0 |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 0 | 0 |
Stock issuance costs | | | | 0 | 0 |
Acquisition of partnership units | | | | | 0 |
Dividends paid | | | | 0 | 0 |
Intercompany borrowings | | | | 0 | 0 |
Borrowings from credit facility | | | | 0 | 0 |
Payments on credit facility | | | | 0 | |
Payments on capital leases and leasing financing arrangements | | | | 0 | 0 |
Tax payment upon exercise of equity awards | | | | 0 | |
Contributions/distributions from parent | | | | 0 | 0 |
Debt issuance costs | | | | 0 | |
Net cash provided by financing activities | | | | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | | | | 0 | 0 |
Cash and cash equivalents at beginning of period | | 0 | | 0 | 0 |
Cash and cash equivalents at end of period | 0 | | 0 | 0 | 0 |
Guarantor Subsidiaries | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | 19,900,000 | | 1,400,000 | 36,800,000 | 1,800,000 |
Equity income (loss) related to investment in subsidiaries | | | | 1,400,000 | 1,600,000 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 44,100,000 | | 30,700,000 | 82,700,000 | 61,200,000 |
Non-cash interest expense | | | | 0 | 0 |
Stock-based compensation expense | | | | 6,200,000 | 6,200,000 |
Provision for bad debt | | | | 700,000 | 200,000 |
Asset impairments and loss on disposal | | | | 0 | 8,600,000 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | (8,700,000) | (6,600,000) |
Accounts payable and accrued expenses | | | | 1,500,000 | (7,700,000) |
Deferred revenues | | | | (7,000,000) | 800,000 |
Due to affiliates | | | | | (1,900,000) |
Net cash provided by operating activities | | | | 113,600,000 | 64,200,000 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | (131,100,000) | (17,300,000) |
Capital expenditures – other development | | | | (246,500,000) | (74,400,000) |
Investment in subsidiaries | | | | 0 | 373,300,000 |
Changes in restricted cash | | | | 1,200,000 | |
Return of investment | | | | 0 | (5,200,000) |
Intercompany borrowings | | | | 0 | |
Intercompany contributions/distributions | | | | | 0 |
Net cash used in investing activities | | | | (376,400,000) | 276,400,000 |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 0 | 0 |
Stock issuance costs | | | | 0 | 0 |
Acquisition of partnership units | | | | | 0 |
Dividends paid | | | | 0 | (33,800,000) |
Intercompany borrowings | | | | 10,800,000 | 70,000,000 |
Borrowings from credit facility | | | | 0 | 0 |
Payments on credit facility | | | | 0 | |
Payments on capital leases and leasing financing arrangements | | | | (3,800,000) | (1,600,000) |
Tax payment upon exercise of equity awards | | | | 0 | |
Contributions/distributions from parent | | | | 256,300,000 | 0 |
Debt issuance costs | | | | 0 | |
Net cash provided by financing activities | | | | 263,300,000 | 34,600,000 |
Net increase (decrease) in cash and cash equivalents | | | | 500,000 | 375,200,000 |
Cash and cash equivalents at beginning of period | | 10,400,000 | | 10,400,000 | 33,500,000 |
Cash and cash equivalents at end of period | 10,900,000 | | 408,700,000 | 10,900,000 | 408,700,000 |
Non-Guarantor Subsidiaries | | | | | |
Condensed Consolidating Statements of Cash Flows | | | | | |
Net income (loss) | (700,000) | | (800,000) | (1,400,000) | (1,600,000) |
Equity income (loss) related to investment in subsidiaries | | | | 0 | 0 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 600,000 | | 700,000 | 1,300,000 | 1,300,000 |
Non-cash interest expense | | | | 0 | 0 |
Stock-based compensation expense | | | | 0 | 0 |
Provision for bad debt | | | | 0 | 0 |
Asset impairments and loss on disposal | | | | 0 | 0 |
Change in operating assets and liabilities: | | | | | |
Rent receivables and other assets | | | | (200,000) | 1,700,000 |
Accounts payable and accrued expenses | | | | 200,000 | 100,000 |
Deferred revenues | | | | 0 | 0 |
Due to affiliates | | | | | 0 |
Net cash provided by operating activities | | | | (100,000) | 1,500,000 |
Cash flows from investing activities: | | | | | |
Capital expenditures – purchase of fixed assets | | | | 0 | 0 |
Capital expenditures – other development | | | | (600,000) | 200,000 |
Investment in subsidiaries | | | | 0 | 0 |
Changes in restricted cash | | | | 0 | |
Return of investment | | | | 0 | 0 |
Intercompany borrowings | | | | (300,000) | |
Intercompany contributions/distributions | | | | | 0 |
Net cash used in investing activities | | | | (900,000) | 200,000 |
Cash flows from financing activities: | | | | | |
Issuance of common stock | | | | 0 | 0 |
Stock issuance costs | | | | 0 | 0 |
Acquisition of partnership units | | | | | 0 |
Dividends paid | | | | 0 | 0 |
Intercompany borrowings | | | | 0 | 0 |
Borrowings from credit facility | | | | 0 | 0 |
Payments on credit facility | | | | 0 | |
Payments on capital leases and leasing financing arrangements | | | | (600,000) | (500,000) |
Tax payment upon exercise of equity awards | | | | 0 | |
Contributions/distributions from parent | | | | 0 | 600,000 |
Debt issuance costs | | | | 0 | |
Net cash provided by financing activities | | | | (600,000) | 100,000 |
Net increase (decrease) in cash and cash equivalents | | | | (1,600,000) | 1,800,000 |
Cash and cash equivalents at beginning of period | | $ 3,900,000 | | 3,900,000 | 3,000,000 |
Cash and cash equivalents at end of period | $ 2,300,000 | | $ 4,800,000 | $ 2,300,000 | $ 4,800,000 |